Intracranial Aneurysm Market: Global Industry Analysis and Forecast (2024-2030)

  • The Intracranial Aneurysm Market size was valued at USD 1.4 Bn. in 2023 and the Intracranial Aneurysm revenue is expected to grow at a CAGR of 8.2% from 2024 to 2030, reaching nearly USD 2.43 Bn. by 2030.

  • Format : PDF | Report ID : SMR_2210

Intracranial Aneurysm Market Overview:

Intracranial aneurysms, characterized by the bulging and weakening of arterial walls in the brain, lead to swelling and potential nerve dysfunction. The global intracranial aneurysm market is growing thanks to the increasing prevalence of aneurysms, particularly among the aging population. The market growth is driven by advancements in treatment Aneurysm technologies, such as surgical clipping, endovascular therapy, and medical therapies, addressing the need for effective solutions.

 

Geographically, the market spans North America, Europe, Asia-Pacific, and other regions, with North America holding a significant share thanks to advanced healthcare infrastructure and high awareness. Distribution channels include hospitals, specialty clinics, and online platforms, ensuring widespread product availability. Companies in the market generate substantial revenue from the sale of aneurysm treatment solutions, supported by increasing demand from healthcare providers and patients.

 

The market performance is strong, with a notable rise in demand and supply of advanced Aneurysm treatment options. Segments expected to grow include endovascular therapy devices and adjunctive devices, driven by technological innovations and improved patient outcomes. End-user contributions come from hospitals, ambulatory surgical centers, and specialized clinics, with key players like Medtronic, Stryker Corporation, and Johnson & Johnson leading the market. These companies focus on research and development to enhance treatment efficacy and grow their product offerings.

Intracranial Aneurysm Market

 

To get more Insights: Request Free Sample Report

 

Intracranial Aneurysm Market Dynamics:

Intracranial Aneurysm Market Drivers

Rising Prevalence of Aneurysms to propel the market growth

The rising prevalence of aneurysms has significant implications for mental health, impacting patients, their families, and caregivers in various ways and prevalence of intracranial aneurysms, particularly among stroke patients, underscores significant implications for the market. Studies indicate a 70% higher risk of intracranial aneurysms in stroke patients compared to the general population, emphasizing the elevated vascular burden and cerebrovascular sensitivity in this group. Additionally, a family history of stroke independently heightens the risk of unruptured intracranial aneurysms (UIA). This demographic shift towards higher incidences of UIA among stroke patients and those with familial stroke history highlights a growing patient pool necessitating advanced diagnostic and therapeutic interventions, thereby shaping the dynamics of the market.

 

The Evolution of Current Surgical Treatment Options

The progress of surgical treatment for intracranial aneurysms has been marked by significant advancements. Innovations like Norlen and Olivecrona's winged blades and Drake's fenestrated designs have vastly improved surgical precision and outcomes. Metallurgical advancements enabling MRI compatibility and refined applicator designs have further enhanced safety and efficacy. The milestones represent a transformative shift in the intracranial aneurysm market and offering neurosurgeons more effective tools to treat patients with greater precision and reduced risk, ultimately improving patient outcomes and quality of life.

 

Intracranial Aneurysm Market opportunities

The increasing awareness of intracranial aneurysms is significantly impacting the market by promoting earlier diagnosis and treatment. With heightened awareness among both the public and healthcare providers, there is a greater emphasis on screening and monitoring, potentially reducing the incidence of ruptures and improving patient outcomes. This shift towards proactive management is driving demand for advanced diagnostic technologies and minimally invasive treatment options in the intracranial aneurysm market. Also, ongoing education and awareness campaigns are fostering collaborations between healthcare stakeholders to enhance patient care and outcomes, reflecting a positive trajectory for innovation and investment in this critical area of neurology.

Intracranial Aneurysm Market1

Intracranial Aneurysm Market Challenges

The intracranial aneurysm market faces several challenges that impact its growth potential. High treatment costs, including expensive devices and procedures, strain both patients and healthcare systems. Complex reimbursement processes and limited insurance coverage hinder adoption of new technologies. Uncertainties in aneurysm rupture risk assessment and treatment efficacy complicate clinical decision-making. Additionally, there is a shortage of skilled neurointerventionalists and unequal access to care globally. These challenges collectively impede market growth by limiting patient access, discouraging investment, and straining healthcare budgets.

 

Addressing these hurdles requires cost-effective innovations, streamlined reimbursement pathways, advanced diagnostics, enhanced physician training, and improved patient education. Collaborative efforts among stakeholders can mitigate these challenges, fostering a more sustainable and accessible intracranial aneurysm treatment landscape while improving patient outcomes.

 

Intracranial Aneurysm Market Segment Analysis:                                           

By Type, the Surgical Clipping segment held XX% of market share in 2023. Surgical clipping, despite being a traditional method, remains crucial in the intracranial aneurysm market segment. It boasts proven efficacy with high long-term occlusion rates for suitable aneurysms, making it highly reliable. Surgeon familiarity and extensive training in clipping procedures ensure its widespread availability. Clipping's versatility allows it to address various aneurysm types, shapes, and locations, making it a comprehensive treatment option. Its durability, offering definitive treatment and potentially reducing future re-rupture risk, further solidifies its significance in the market.

Intracranial Aneurysm Market2

Technological advancements in the market are revolutionizing treatment approaches. Minimally invasive techniques like mini-craniotomy and endoscopic clipping are increasing treatment options, improving recovery times, and reducing patient discomfort. Enhanced visualization tools such as high-resolution microscopes and fluorescent angiography are enhancing surgical precision and potentially minimizing complications. Real-time navigation systems are improving procedural accuracy and efficiency and contributing to better patient outcomes.

 

The emergence of robotic-assisted clipping offers the promise of even greater precision and faster recovery, though it is currently in early stages of development. These advancements collectively represent significant strides in improving the efficacy, safety, and patient experience in the management of intracranial aneurysms.

 

End-user contributions are pivotal in the intracranial aneurysm market. Surgeon expertise in clipping techniques is essential for successful outcomes, emphasizing ongoing training and adoption of new technologies. Patient selection based on aneurysm characteristics and health factors remains critical, requiring shared decision-making between surgeons and patients. Patient advocacy groups play a crucial role in raising awareness about aneurysms and treatment options like clipping. They also contribute to research efforts aimed at advancing clipping techniques and improving patient outcomes, thereby influencing the aneurysm care landscape.

 

Intracranial Aneurysm Market Regional Insight

North America holds XX% of the intracranial aneurysm market share thanks to its advanced healthcare infrastructure, high prevalence of risk factors like smoking and high blood pressure, and substantial healthcare expenditure. Easy access to specialists, advanced diagnostics, and treatment facilities, combined with the region's ability to afford expensive treatments, drives market dominance.

Intracranial Aneurysm Market3

  • The United States holds the majority share within North America thanks to its highly developed healthcare system, providing widespread access to specialists, advanced diagnostics, and treatment facilities. The high prevalence of risk factors such as smoking, high blood pressure, and genetic predispositions contribute to a larger patient pool. Additionally, high healthcare spending ensures that patients afford expensive treatments more readily than in other regions, further increasing the Intracranial Aneurysm Market share.
  • Canada is a significant player in the intracranial aneurysm market, supported by a well-developed healthcare system that ensures access to advanced diagnostics and treatment facilities. However, the market size smaller compared to the United States due to population differences. Despite this, Canada's high standards of healthcare, comprehensive coverage, and increasing awareness of neurological disorders contribute to steady Intracranial Aneurysm Market growth and effective management of intracranial aneurysms.

 

Asia-Pacific holds XX% of the market and shows the fastest growth thanks to a rapidly aging population, making more individuals susceptible to aneurysms. Rising disposable incomes in the region increase the affordability of treatments, while growing awareness of neurological disorders leads to more diagnoses and treatment. These factors contribute to the region's growing market share and driving significant growth in the intracranial aneurysm market.

 

Intracranial Aneurysm Market Competitive Landscape:

The global intracranial aneurysm market is highly competitive, with major players driving growth through cost-efficient, advanced product innovations. Key strategies such as technical partnerships and mergers and acquisitions are crucial as companies aim for a competitive edge and market leadership amidst rising demand.

 

The intracranial aneurysm market is expected to grow significantly thanks to the rising prevalence of aneurysms and the increasing adoption of minimally invasive treatments. The competitive landscape features major players like Stryker Corporation and Medtronic. Stryker, a market share leader, boasts a long history, a broad product portfolio (coiling, stents, etc.), strong R&D capabilities, and a global distribution network. However, its products are often pricier, and it slower to adopt new technologies. Conversely, Medtronic focuses on specific aneurysm treatment segments with cost-effective solutions, demonstrating agility in adopting new technologies and a strong regional presence, especially in emerging markets. Its weaknesses include a smaller market share, a limited product portfolio, and less global brand recognition.

 

Intracranial Aneurysm Market Scope: 

Intracranial Aneurysm Market

Market Size in 2023

USD 1.4 Bn.

Market Size in 2030

USD 2.43 Bn.

CAGR (2024-2030)

8.2 %

Historic Data

2018-2022

Base Year

2023

Forecast Period

2024-2030

   Segments

By Type

Surgical Clipping

Endovascular Coiling

Flow Diverters

Others

By End User    

Hospitals

Clinics

Others

Regional Scope

North America- United States, Canada, and Mexico

Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe

Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa

South America – Brazil, Argentina, Rest of South America

 

Intracranial Aneurysm Market Key Players:

  • Medtronic
  • MicroPort Scientific Corporation
  • B.Braun
  • Stryker
  • Johnson and Johnson Services Inc.
  • Microvention Inc.
  • Codman Neuro (Integra Lifesciences)
  • Renolit
  • Integra LifeSciences
  • RAUMEDIC AG
  • Terumo Corporation
  • Delta Surgical
  • Mizuho Medical Incorporation
  • Evonos GmbH & Co. KG,
  • Integra Life-science Holding Corporation
  • Delta Surgical
  • XXX,Inc.


Frequently Asked Questions

Advancements in Treatment Technologies and Improved Healthcare Infrastructure are driving the Intracranial Aneurysm Market.

1.    Intracranial Aneurysm Market: Research Methodology 
2.    Intracranial Aneurysm Market: Executive Summary
3.    Intracranial Aneurysm Market: Competitive Landscape

3.1. Stellar Competition Matrix
3.2. Competitive Landscape
3.3. Key Players Benchmarking
3.4. Market Structure
3.4.1.    Market Leaders 
3.4.2.    Market Followers
3.4.3.    Emerging Players

3.5. Consolidation of the Market
4.    Intracranial Aneurysm Market: Dynamics
4.1. Market Driver 
4.2. Market Trends by Region
4.2.1.    North America
4.2.2.    Europe
4.2.3.    Asia Pacific
4.2.4.    Middle East and Africa
4.2.5.    South America

4.3. Market Restraints
4.4. Market Opportunities
4.5. Market Challenges
4.6. PORTER’s Five Forces Analysis
4.7. PESTLE Analysis
4.8. Strategies for New Entrants to Penetrate the Market
4.9. Regulatory Landscape by Region
4.9.1.    North America
4.9.2.    Europe
4.9.3.    Asia Pacific
4.9.4.    Middle East and Africa
4.9.5.    South America

5.    Intracranial Aneurysm Market Size and Forecast by Segmentations (by Value USD Billion)
5.1. Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
5.1.1.    Surgical Clipping
5.1.2.    Endovascular Coiling
5.1.3.    Flow Diverters
5.1.4.    Others 

5.2. Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
5.2.1.    Hospitals
5.2.2.    Clinics
5.2.3.    Others 

5.3. Intracranial Aneurysm Market Size and Forecast, by Region (2023-2030)
5.3.1.    North America
5.3.2.    Europe
5.3.3.    Asia Pacific
5.3.4.    Middle East and Africa
5.3.5.    South America

6.    North America Intracranial Aneurysm Market Size and Forecast (by Value USD Billion)
6.1. North America Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
6.1.1.    Surgical Clipping
6.1.2.    Endovascular Coiling
6.1.3.    Flow Diverters
6.1.4.    Others

6.2. North America Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
6.2.1.    Hospitals
6.2.2.    Clinics
6.2.3.    Others 

6.3. North America Intracranial Aneurysm Market Size and Forecast, by Country (2023-2030)
6.3.1.    United States
6.3.2.    Canada
6.3.3.    Mexico

7.    Europe Intracranial Aneurysm Market Size and Forecast (by Value USD Billion)
7.1. Europe Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
7.1.1.    Surgical Clipping
7.1.2.    Endovascular Coiling
7.1.3.    Flow Diverters
7.1.4.    Others

7.2. Europe Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
7.2.1.    Hospitals
7.2.2.    Clinics 
7.2.3.    Others
 
7.3. Europe Intracranial Aneurysm Market Size and Forecast, by Country (2023-2030)
7.3.1.    UK
7.3.2.    France
7.3.3.    Germany
7.3.4.    Italy
7.3.5.    Spain
7.3.6.    Sweden
7.3.7.    Russia 
7.3.8.    Rest of Europe

8.    Asia Pacific Intracranial Aneurysm Market Size and Forecast (by Value USD Billion)
8.1. Asia Pacific Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
8.1.1.    Surgical Clipping
8.1.2.    Endovascular Coiling
8.1.3.    Flow Diverters
8.1.4.    Others 

8.2. Asia Pacific Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
8.2.1.    Hospitals
8.2.2.    Clinics
8.2.3.    Others 

8.3. Asia Pacific Intracranial Aneurysm Market Size and Forecast, by Country (2023-2030)
8.3.1.    China
8.3.2.    S Korea
8.3.3.    Japan
8.3.4.    India
8.3.5.    Australia
8.3.6.    Indonesia 
8.3.7.    Malaysia
8.3.8.    Vietnam
8.3.9.    Taiwan
8.3.10.    Bangladesh
8.3.11.    Pakistan
8.3.12.    Rest of Asia Pacific

9.    Middle East and Africa Intracranial Aneurysm Market Size and Forecast (by Value USD Billion)
9.1. Middle East and Africa Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
9.1.1.    Surgical Clipping
9.1.2.    Endovascular Coiling
9.1.3.    Flow Diverters
9.1.4.    Others

9.2. Middle East and Africa Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
9.2.1.    Hospitals
9.2.2.    Clinics 
9.2.3.    Others 

9.3. Middle East and Africa Intracranial Aneurysm Market Size and Forecast, by Country (2023-2030)
9.3.1.    South Africa
9.3.2.    GCC
9.3.3.    Egypt
9.3.4.    Nigeria
9.3.5.    Rest of ME&A

10.    South America Intracranial Aneurysm Market Size and Forecast (by Value USD Billion)
10.1. South America Intracranial Aneurysm Market Size and Forecast, by Type (2023-2030)
10.1.1.    Surgical Clipping
10.1.2.    Endovascular Coiling
10.1.3.    Flow Diverters
10.1.4.    Others 

10.2. South America Intracranial Aneurysm Market Size and Forecast, by End User (2023-2030)
10.2.1.    Hospitals
10.2.2.    Clinics 
10.2.3.    Others 

10.3. South America Intracranial Aneurysm Market Size and Forecast, by Country (2023-2030)
10.3.1.    Brazil
10.3.2.    Argentina
10.3.3.    Rest of South America

11.    Company Profile: Key players
11.1. Medtronic
11.1.1.    Company Overview
11.1.2.    Financial Overview
11.1.3.    Business Portfolio
11.1.4.    SWOT Analysis
11.1.5.    Business Strategy 
11.1.6.    Recent Development

11.2. MicroPort Scientific Corporation
11.3. B.Braun
11.4. Stryker
11.5. Johnson and Johnson Services Inc.
11.6. Microvention Inc.
11.7. Codman Neuro (Integra Lifesciences)
11.8. Renolit
11.9. Integra LifeSciences
11.10. RAUMEDIC AG
11.11. Terumo Corporation
11.12. Delta Surgical
11.13. Mizuho Medical Incorporation
11.14. Evonos GmbH & Co. KG, 
11.15. Integra Life-science Holding Corporation
11.16. Delta Surgical 
11.17. XXX, Inc. 
12.    Key Findings
13.    Industry Recommendations

Enquiry Before Buy


Request Sample PDF